Company Profile: PGXIS Ltd. (September 2011)

• Record Type: Journal Article
• Authors: McCarthy, Alun
• Is Part Of: Pharmacogenomics. Volume 12:Number 9(2011)
• Page Start: 1253
• Page End: 1256
• Publication Date: 2011-09
• Subjects: drug development -- personalized medicine -- pharmacogenetics -- siRNA -- Tax3 analysis; Pharmacogenomics -- Periodicals; 615.1
• DOI: 10.2217/pgs.11.87
• Languages: English
• ISSNs: 1462-2416

Abstract

Pharmacogenomic Innovative Solutions Ltd (PGXIS) was established in 2007 by a group of pharmacogenomic (PGx) experts to make their expertise available to biotechnology and pharmaceutical companies. PGXIS has subsequently established a network of experts to broaden its access to relevant PGx knowledge and technologies. In addition, it has developed a novel multivariate analysis method called Taxonomy3 which is both a data integration tool and a targeting tool. Together with siRNA methodology from CytoPathfinder Inc., PGXIS now has an extensive range of diverse PGx methodologies focused on enhancing drug development.